EUVIMEDOpdag EUVIMED
Systematische Übersicht

Clinical Practice Recommendations on the Effect of COVID‐19 Vaccination Strategies on Outcomes in Solid Organ Transplant Recipients

Farid Foroutan iD, Daniel G Rayner, Shelly Oss, Marco Straccia, Rienk de Vries, Shilpa Raju, Farhin Ahmed, Jennifer Kingdon, Sai Bhagra iD, Shafrina Tarani, Sabina Herrera, Rahima Bhanji iD and 7 more

Clinical Transplantation · 2025

DOI: 10.1111/ctr.70100 ↗

At a glance

Systematische Übersicht in Clinical Transplantation, 2025. Written by Farid Foroutan and 18 co-authors. Institution: Department of Health Research Methods, Evidence, and Impact, Faculty of Health Sciences, McMaster University, Hamilton, Canada. Major MEDLINE topics: COVID-19, COVID-19 Vaccines, Organ Transplantation, Vaccination. Cited 3 times so far (Crossref); 62 references. Funded by: Canadian Donation and Transplantation Research Program Research Innovation Award.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Introduction

Solid organ transplant (SOT) recipients were excluded from clinical trials evaluating the efficacy of COVID‐19 vaccines. There is uncertainty about the number of doses required to prevent life‐threatening infection, as well as uncertainty in the optimal vaccine type and their durability. Our objectives were to provide recommendations on the number of COVID‐19 vaccination doses, type of vaccine, dose of vaccine administered, and timing of vaccination in SOT recipients.

Methods

We commissioned a systematic review on COVID‐19 vaccination in SOT, focusing on patient‐important outcomes. We recruited an international, multidisciplinary panel of 18 stakeholders, including patient partners to summarize our findings using the GRADE (grading of recommendation, assessment, development, and evaluation) framework, rate certainty in the evidence, and develop recommendations.

Results

Our panel recommends the routine provision of additional COVID‐19 doses after the primary series to SOT recipients with variant‐appropriate vaccines (strong recommendation, low certainty evidence). We suggest using any available WHO‐approved vaccine rather than selectively choosing a specific type and receiving a single dose rather than a double dose of any COVID‐19 vaccine booster (weak recommendation, low certainty evidence). Lastly, we suggest vaccination before transplantation when possible (weak recommendation, low certainty evidence).

Conclusion

The evidence used to guide these recommendations is limited by the paucity of robust randomized trials evaluating COVID‐19 vaccination strategies and clinical outcomes in the SOT population. The provision of higher‐quality evidence of the overall effects of COVID‐19 vaccination in SOT to inform clinical practice will require large, randomized trials.

Subjects

MeSH terms (MEDLINE)

COVID-19COVID-19 VaccinesOrgan TransplantationVaccinationTransplant RecipientsPractice Guidelines as TopicHumansSARS-CoV-2

Author keywords

COVID‐19solid organ transplantationvaccination

Substances

COVID-19 Vaccines

Authors and institutions

  • Department of Health Research Methods, Evidence, and Impact, Faculty of Health Sciences, McMaster University, Hamilton, Canada.
  • Ted Rogers Centre for Heart Research, University Health Network, Toronto, Canada.
  • FRESCI by Science & Strategy, Barcelona, Spain.
  • Patient and Caregiver Partner, Canadian Donation and Transplantation Research Program, Edmonton, Alberta, Canada.
  • Centre for Primary Care, Queen Mary University, London, UK.
  • Royal Papworth Hospital, Cambridge, UK.

ORCID profiles: Farid Foroutan, Sai Bhagra, Rahima Bhanji, Marcus Pereira, Coleman Rotstein, Natasha Aleksova

Funding

  • Canadian Donation and Transplantation Research Program Research Innovation Award

Cite

APA

Foroutan, F., Rayner, D. G., Oss, S., Straccia, M., de Vries, R., Raju, S., Ahmed, F., Kingdon, J., Bhagra, S., Tarani, S., Herrera, S., Bhanji, R., Ross, H., Pruett, T., Feng, S., Pereira, M., Rotstein, C., Guyatt, G., & Aleksova, N. (2025). Clinical Practice Recommendations on the Effect of COVID‐19 Vaccination Strategies on Outcomes in Solid Organ Transplant Recipients. Clinical Transplantation. https://doi.org/10.1111/ctr.70100

Vancouver

Foroutan F, Rayner DG, Oss S, Straccia M, de Vries R, Raju S, et al. Clinical Practice Recommendations on the Effect of COVID‐19 Vaccination Strategies on Outcomes in Solid Organ Transplant Recipients. Clinical Transplantation. 2025. doi:10.1111/ctr.70100

BibTeX
@article{Foroutan2025,
  author = {Foroutan, Farid and Rayner, Daniel G and Oss, Shelly and Straccia, Marco and de Vries, Rienk and Raju, Shilpa and Ahmed, Farhin and Kingdon, Jennifer and Bhagra, Sai and Tarani, Shafrina and Herrera, Sabina and Bhanji, Rahima and Ross, Heather and Pruett, Timothy and Feng, Sandy and Pereira, Marcus and Rotstein, Coleman and Guyatt, Gordon and Aleksova, Natasha},
  title = {Clinical Practice Recommendations on the Effect of COVID‐19 Vaccination Strategies on Outcomes in Solid Organ Transplant Recipients},
  journal = {Clinical Transplantation},
  year = {2025},
  doi = {10.1111/ctr.70100}
}
Start for free →